These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 15234592)

  • 21. The nociceptin/orphanin FQ antagonist UFP-101 differentially modulates the glucocorticoid response to restraint stress in rats during the peak and nadir phases of the hypothalamo-pituitary-adrenal axis circadian rhythm.
    Leggett JD; Jessop DS; Fulford AJ
    Neuroscience; 2007 Jul; 147(3):757-64. PubMed ID: 17574767
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Feeding and locomotion responses to centrally injected nociceptin/orphanin FQ in chicks.
    Abbasnejad M; Jonaidi H; Denbow DM; Pour Rahimi AM
    Physiol Behav; 2005 Jul; 85(4):383-6. PubMed ID: 16002102
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of nociceptin/orphanin FQ and NOP receptors in the response to acute and repeated restraint stress in rats.
    Delaney G; Dawe KL; Hogan R; Hunjan T; Roper J; Hazell G; Lolait SJ; Fulford AJ
    J Neuroendocrinol; 2012 Dec; 24(12):1527-41. PubMed ID: 22835008
    [TBL] [Abstract][Full Text] [Related]  

  • 24. NOP agonists prevent the antidepressant-like effects of nortriptyline and fluoxetine but not R-ketamine.
    Holanda VAD; Santos WB; Asth L; Guerrini R; Calo' G; Ruzza C; Gavioli EC
    Psychopharmacology (Berl); 2018 Nov; 235(11):3093-3102. PubMed ID: 30145654
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nociceptin/orphanin FQ and related peptides reduce the increase in plasma corticosterone elicited in mice by an intracerebroventricular injection.
    Le Cudennec C; Naudin B; Do Rego JC; Costentin J
    Life Sci; 2002 Nov; 72(2):163-71. PubMed ID: 12417250
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The nociceptin/orphanin FQ receptor (NOP) as a target for drug abuse medications.
    Zaveri NT
    Curr Top Med Chem; 2011; 11(9):1151-6. PubMed ID: 21050175
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Activation of NOP receptor increases vulnerability to stress: role of glucocorticoids and CRF signaling.
    Holanda VAD; de Almeida RN; de Oliveira MC; da Silva Junior ED; Galvão-Coelho NL; Calo' G; Ruzza C; Gavioli EC
    Psychopharmacology (Berl); 2024 May; 241(5):1001-1010. PubMed ID: 38270614
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacological characterization of the novel nonpeptide orphanin FQ/nociceptin receptor agonist Ro 64-6198: rapid and reversible desensitization of the ORL1 receptor in vitro and lack of tolerance in vivo.
    Dautzenberg FM; Wichmann J; Higelin J; Py-Lang G; Kratzeisen C; Malherbe P; Kilpatrick GJ; Jenck F
    J Pharmacol Exp Ther; 2001 Aug; 298(2):812-9. PubMed ID: 11454946
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Swim stress enhances nociceptin/orphanin FQ-induced inhibition of rat dorsal raphe nucleus activity in vivo and in vitro: role of corticotropin releasing factor.
    Nazzaro C; Barbieri M; Varani K; Beani L; Valentino RJ; Siniscalchi A
    Neuropharmacology; 2010 Feb; 58(2):457-64. PubMed ID: 19747494
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epigenetic regulation of nociceptin/orphanin FQ and corticotropin-releasing factor system genes in frustration stress-induced binge-like palatable food consumption.
    Pucci M; Micioni Di Bonaventura MV; Giusepponi ME; Romano A; Filaferro M; Maccarrone M; Ciccocioppo R; Cifani C; D'Addario C
    Addict Biol; 2016 Nov; 21(6):1168-1185. PubMed ID: 26387568
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Roles of the bed nucleus of stria terminalis and of the amygdala in N/OFQ-mediated anxiety and HPA axis activation.
    Green MK; Barbieri EV; Brown BD; Chen KW; Devine DP
    Neuropeptides; 2007 Dec; 41(6):399-410. PubMed ID: 17980908
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nociceptin and the NOP receptor in aversive learning in mice.
    Adem A; Madjid N; Kahl U; Holst S; Sadek B; Sandin J; Terenius L; Ögren SO
    Eur Neuropsychopharmacol; 2017 Dec; 27(12):1298-1307. PubMed ID: 29102248
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Beta-arrestin 2 rather than G protein efficacy determines the anxiolytic-versus antidepressant-like effects of nociceptin/orphanin FQ receptor ligands.
    Asth L; Ruzza C; Malfacini D; Medeiros I; Guerrini R; Zaveri NT; Gavioli EC; Calo' G
    Neuropharmacology; 2016 Jun; 105():434-442. PubMed ID: 26867504
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Functional selectivity of nociceptin/orphanin FQ peptide receptor partial agonists on cardiovascular and renal function.
    Kapusta DR; Burmeister MA; Calo' G; Guerrini R; Gottlieb HB; Kenigs VA
    J Pharmacol Exp Ther; 2005 Aug; 314(2):643-51. PubMed ID: 15855356
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacological characterization of nociceptin/orphanin FQ receptors, a novel opioid receptor family, in the midbrain periaqueductal gray.
    Chiou LC; Fan SH; Chuang KC; Liao YY; Lee SZ
    Ann N Y Acad Sci; 2004 Oct; 1025():398-403. PubMed ID: 15542742
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nociceptin/orphanin FQ peptide receptors: pharmacology and clinical implications.
    Chiou LC; Liao YY; Fan PC; Kuo PH; Wang CH; Riemer C; Prinssen EP
    Curr Drug Targets; 2007 Jan; 8(1):117-35. PubMed ID: 17266536
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Endogenous opiates and behavior: 2012.
    Bodnar RJ
    Peptides; 2013 Dec; 50():55-95. PubMed ID: 24126281
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel potent agonist [(pF)Phe4,Aib7,Aib11,Arg14,Lys15]N/OFQ-NH2 and antagonist [Nphe1,(pF)Phe4,Aib7,Aib11,Arg14,Lys15]N/OFQ-NH2 of nociceptin/orphanin FQ receptor.
    Peng YL; Chang M; Dong SL; Li W; Han RW; Fu GX; Chen Q; Wang R
    Regul Pept; 2006 May; 134(2-3):75-81. PubMed ID: 16516988
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of serotonin outflow by nociceptin/orphaninFQ in dorsal raphe nucleus slices from normal and stressed rats: Role of corticotropin releasing factor.
    Nazzaro C; Marino S; Barbieri M; Siniscalchi A
    Neurochem Int; 2009; 54(5-6):378-84. PubMed ID: 19418633
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of novel NOP receptor ligands on food intake in rats.
    Economidou D; Policani F; Angellotti T; Massi M; Terada T; Ciccocioppo R
    Peptides; 2006 Apr; 27(4):775-83. PubMed ID: 16483692
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.